Anna Coenen-Stass

1.9k total citations
28 papers, 1.1k citations indexed

About

Anna Coenen-Stass is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Anna Coenen-Stass has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Anna Coenen-Stass's work include Muscle Physiology and Disorders (11 papers), MicroRNA in disease regulation (7 papers) and Extracellular vesicles in disease (5 papers). Anna Coenen-Stass is often cited by papers focused on Muscle Physiology and Disorders (11 papers), MicroRNA in disease regulation (7 papers) and Extracellular vesicles in disease (5 papers). Anna Coenen-Stass collaborates with scholars based in United Kingdom, United States and Germany. Anna Coenen-Stass's co-authors include Matthew J. A. Wood, Thomas C. Roberts, Pradeep D. Uchil, Jeremy Luban, Walther Mothes, Steven J. Siegel, Thomas Pertel, Corinne Betts, Graham McClorey and Imre Mäger and has published in prestigious journals such as Journal of Clinical Oncology, Nano Letters and Nature Neuroscience.

In The Last Decade

Anna Coenen-Stass

27 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Coenen-Stass United Kingdom	17	741	272	238	136	83	28	1.1k
Stephen M. Lewis Canada	21	1.5k 2.0×	451 1.7×	163 0.7×	109 0.8×	187 2.3×	44	1.7k
Rainer Will Germany	19	763 1.0×	311 1.1×	140 0.6×	202 1.5×	249 3.0×	50	1.3k
Darja Karpova United States	15	520 0.7×	183 0.7×	290 1.2×	261 1.9×	18 0.2×	27	956
Hongbo Lu United States	12	519 0.7×	176 0.6×	253 1.1×	174 1.3×	18 0.2×	28	1.1k
Dale O. Cowley United States	15	631 0.9×	170 0.6×	125 0.5×	202 1.5×	22 0.3×	29	875
Juho J. Miettinen Finland	10	479 0.6×	106 0.4×	244 1.0×	166 1.2×	90 1.1×	26	790
Allen Chung United States	8	578 0.8×	262 1.0×	516 2.2×	138 1.0×	73 0.9×	12	1.0k
Jens Bo Hansen Denmark	12	1.2k 1.6×	684 2.5×	228 1.0×	137 1.0×	28 0.3×	17	1.6k
Brandon E. Kremer United States	14	833 1.1×	90 0.3×	70 0.3×	192 1.4×	58 0.7×	37	1.2k
Paul Chuchana France	21	763 1.0×	326 1.2×	364 1.5×	195 1.4×	27 0.3×	47	1.4k

Countries citing papers authored by Anna Coenen-Stass

Since Specialization

Citations

This map shows the geographic impact of Anna Coenen-Stass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Coenen-Stass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Coenen-Stass more than expected).

Fields of papers citing papers by Anna Coenen-Stass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Coenen-Stass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Coenen-Stass. The network helps show where Anna Coenen-Stass may publish in the future.

Co-authorship network of co-authors of Anna Coenen-Stass

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Coenen-Stass. A scholar is included among the top collaborators of Anna Coenen-Stass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Coenen-Stass. Anna Coenen-Stass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tolcher, Anthony W., Lillian L. Siu, Elena Garralda, et al.. (2024). Pharmacokinetic (PK) and pharmacodynamic (PD) findings from a phase 1b study of ATR inhibitor tuvusertib + anti-PD-L1 avelumab in patients with advanced unresectable solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2614–2614. 1 indexed citations

Markowska, Magdalena, Magdalena A. Budzinska, Anna Coenen-Stass, et al.. (2023). Synthetic lethality prediction in DNA damage repair, chromatin remodeling and the cell cycle using multi-omics data from cell lines and patients.. Scientific Reports. 13(1). 7049–7049. 2 indexed citations

Romesser, Paul B., Jaume Capdevila, Rocio García‐Carbonero, et al.. (2023). A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer. Clinical Cancer Research. 30(4). 695–702. 17 indexed citations

Kuczynski, Elizabeth A., Giulia Morlino, Anna Coenen-Stass, et al.. (2022). A preclinical model of peripheral T‐cell lymphoma GATA3 reveals DNA damage response pathway vulnerability. EMBO Molecular Medicine. 14(6). e15816–e15816. 5 indexed citations

Hanson, Britt, Nina Ahlskog, Nenad Svrzikapa, et al.. (2022). Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD. Molecular Therapy — Nucleic Acids. 30. 379–397. 11 indexed citations

Oieni, Jacopo, Joanna Zemła, Małgorzata Lekka, et al.. (2022). Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties. Molecular Therapy — Nucleic Acids. 29. 955–968. 8 indexed citations

Carnevalli, Larissa S., Molly A. Taylor, Matthew King, et al.. (2021). Macrophage Activation Status Rather than Repolarization Is Associated with Enhanced Checkpoint Activity in Combination with PI3Kγ Inhibition. Molecular Cancer Therapeutics. 20(6). 1080–1091. 14 indexed citations

Magen, Iddo, Anna Coenen-Stass, Julian Großkreutz, et al.. (2021). Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis. Nature Neuroscience. 24(11). 1534–1541. 75 indexed citations

Johansson, Henrik J., Britt Hanson, Anna Coenen-Stass, et al.. (2020). Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy. Molecular & Cellular Proteomics. 19(12). 2047–2068. 25 indexed citations

10.

Taylor, Molly A., Adina Hughes, Josephine Walton, et al.. (2019). Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery. Journal for ImmunoTherapy of Cancer. 7(1). 328–328. 70 indexed citations

11.

Coenen-Stass, Anna, Helena Sork, Sole Gatto, et al.. (2018). Comprehensive RNA-Sequencing Analysis in Serum and Muscle Reveals Novel Small RNA Signatures with Biomarker Potential for DMD. Molecular Therapy — Nucleic Acids. 13. 1–15. 38 indexed citations

12.

Carnevalli, Larissa S., Charles Sinclair, Molly A. Taylor, et al.. (2018). PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity. Journal for ImmunoTherapy of Cancer. 6(1). 158–158. 71 indexed citations

13.

Coenen-Stass, Anna, Matthew J. A. Wood, & Thomas C. Roberts. (2017). Biomarker Potential of Extracellular miRNAs in Duchenne Muscular Dystrophy. Trends in Molecular Medicine. 23(11). 989–1001. 48 indexed citations

14.

Coenen-Stass, Anna, Corinne Betts, Imre Mäger, et al.. (2016). Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation. Human Molecular Genetics. 25(18). 3960–3974. 44 indexed citations

15.

Coenen-Stass, Anna, Imre Mäger, & Matthew J. A. Wood. (2015). Extracellular microRNAs in Membrane Vesicles and Non-vesicular Carriers. Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions. 106. 31–53. 8 indexed citations

16.

Coenen-Stass, Anna, Graham McClorey, Raquel Manzano, et al.. (2015). Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics. Scientific Reports. 5(1). 17014–17014. 49 indexed citations

17.

Poupiot, Jérôme, Aleksandar Zocevic, Fatima Amor, et al.. (2015). Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies. Human Molecular Genetics. 24(17). 4916–4932. 50 indexed citations

18.

Betts, Corinne, Amer F. Saleh, Carolyn A. Carr, et al.. (2015). Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice. Scientific Reports. 5(1). 8986–8986. 44 indexed citations

19.

Roberts, Thomas C., Anna Coenen-Stass, & Matthew J. A. Wood. (2014). Assessment of RT-qPCR Normalization Strategies for Accurate Quantification of Extracellular microRNAs in Murine Serum. PLoS ONE. 9(2). e89237–e89237. 96 indexed citations

20.

Roberts, Thomas C., Anna Coenen-Stass, Corinne Betts, & Matthew J. A. Wood. (2014). Detection and quantification of extracellular microRNAs in murine biofluids. Biological Procedures Online. 16(1). 5–5. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact